04RQ0KZ
Replacement Anterior Tibial Artery, Left to No Qualifier with Nonautologous Tissue Substitute, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 4 Lower Arteries |
| Operation | R Replacement |
| Body Part | Q Anterior Tibial Artery, Left |
| Approach | 0 Open |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
Replacement procedures in the lower arteries involve taking out a diseased or damaged arterial segment and putting in synthetic graft material or biological tissue to physically stand in for that piece of vessel. This is distinct from simply patching or reinforcing an artery, since the native segment is functionally substituted rather than preserved and bolstered.
A classic example is an aortobifemoral or femoral-popliteal graft placed after removing a severely diseased, occluded, or aneurysmal segment of artery, using a synthetic conduit such as Dacron or PTFE, or in some cases a harvested vein used as a full segmental replacement. Patients typically arrive at this procedure after conservative management or angioplasty has failed, or when an aneurysm poses a rupture risk that mandates excising the weakened wall.
Anatomy & Axis Detail
Anterior Tibial Artery, Left
The left anterior tibial artery arises from the popliteal artery, passes through the interosseous membrane, and supplies the anterior lower leg compartment before becoming the dorsalis pedis artery at the ankle. Because of its narrow caliber and distal location, isolated replacement of this vessel is uncommon and is generally undertaken only in the setting of severe peripheral arterial disease, diabetic vasculopathy, or trauma threatening foot viability, often as part of a broader distal revascularization strategy when more proximal tibial or peroneal vessels are also compromised. Autologous vein is typically the conduit of choice given the poor patency of synthetic grafts at this small caliber and distal position. Because this artery frequently serves as a distal bypass target rather than the primary site of disease, the operative note should specify whether the procedure constitutes true segmental replacement or an anastomotic bypass endpoint.
Approach: Open
Open approach means the surgeon cuts through skin, mucous membrane, or other tissue layers to physically expose the target site to view before performing the procedure. It gives direct visualization and hands-on access, distinguishing it from Percutaneous approaches where instruments pass through a small puncture without exposing the site. Open is typical for procedures needing wide access, such as most laparotomies.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
The operative report must clearly establish that a segment of native artery was excised or its function replaced, and that a graft or biological material took its place, distinguishing this from Bypass, where the diseased segment is left in place and a new route is constructed around it. Coders should identify the specific arterial body part value replaced and the device value representing the graft material, whether autologous, nonautologous, or synthetic.
A common error is coding a bypass graft as a Replacement when the original artery segment was left intact and simply routed around; another is failing to capture the correct device value when a combination of graft materials was used in a single reconstruction.